We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+4.15%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$5.2B
AUM Growth
-$219M
Cap. Flow
-$370M
Cap. Flow %
-7.11%
Top 10 Hldgs %
18.34%
Holding
708
New
42
Increased
173
Reduced
401
Closed
28

Top Buys

Rank Stock Value
1
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$13.6M
2
ALK icon
Alaska Air
ALK
+$9.49M
3
DAL icon
Delta Air Lines
DAL
+$7.84M
4
MWA icon
Mueller Water Products
MWA
+$4.38M
5
BAC icon
Bank of America
BAC
+$3.31M

Top Sells

Rank Stock Value
1
LVLT
Level 3 Communications Inc
LVLT
+$45.4M
2
KITE
Kite Pharma, Inc.
KITE
+$42.2M
3
LRCX icon
Lam Research
LRCX
+$19.8M
4
RCL icon
Royal Caribbean
RCL
+$13.4M
5
QRVO icon
Qorvo
QRVO
+$11.1M

Sector Composition

Rank Sector Weight
1 Technology 20.94%
2 Communication Services 14.2%
3 Healthcare 13.83%
4 Industrials 9.95%
5 Financials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
76
Gilead Sciences
GILD
$165B
$20.9M 0.4%
291,973
-8,609
-3% -$654K
BA icon
77
Boeing
BA
$169B
$20.5M 0.39%
69,560
-1,875
-3% -$508K
SSP icon
78
E.W. Scripps
SSP
$270M
$20.1M 0.39%
1,286,609
-112,975
-8% -$1.83M
BAC icon
79
Bank of America
BAC
$429B
$19.7M 0.38%
667,041
+120,192
+22% +$3.31M
PNC icon
80
PNC Financial Services
PNC
$99.1B
$17.8M 0.34%
123,175
-3,629
-3% -$501K
VZ icon
81
Verizon
VZ
$197B
$17.8M 0.34%
335,424
-7,010
-2% -$345K
VIAV icon
82
Viavi Solutions
VIAV
$7.95B
$17.5M 0.34%
1,998,957
-197,070
-9% -$1.79M
ETN icon
83
Eaton
ETN
$141B
$17.1M 0.33%
217,037
-40,318
-16% -$3.13M
SRPT icon
84
Sarepta Therapeutics
SRPT
$1.64B
$16.9M 0.32%
303,006
-28,635
-9% -$1.52M
VEA icon
85
Vanguard FTSE Developed Markets ETF
VEA
$223B
$16.2M 0.31%
361,004
+14,568
+4% +$644K
IVV icon
86
iShares Core S&P 500 ETF
IVV
$858B
$16M 0.31%
59,660
+2,639
+5% +$691K
SLB icon
87
SLB Ltd
SLB
$72.7B
$16M 0.31%
237,711
-8,280
-3% -$537K
MGNX icon
88
MacroGenics
MGNX
$233M
$15.5M 0.3%
816,975
-26,200
-3% -$489K
ALDR
89
DELISTED
Alder Biopharmaceuticals
ALDR
$15.4M 0.3%
1,348,630
+138,550
+11% +$1.55M
ABBV icon
90
AbbVie
ABBV
$465B
$15M 0.29%
155,165
-8,341
-5% -$786K
BMY icon
91
Bristol-Myers Squibb
BMY
$129B
$14.9M 0.29%
243,763
+9,157
+4% +$573K
GLW icon
92
Corning
GLW
$107B
$14.3M 0.27%
446,592
-10,812
-2% -$340K
IBM icon
93
IBM
IBM
$213B
$14.2M 0.27%
97,074
-5,258
-5% -$765K
AGN
94
DELISTED
Allergan plc
AGN
$14.1M 0.27%
86,045
+8,322
+11% +$1.49M
MET icon
95
MetLife
MET
$62.4B
$14M 0.27%
276,745
-14,083
-5% -$742K
META icon
96
Meta Platforms (Facebook)
META
$1.49T
$13.8M 0.27%
78,191
-2,285
-3% -$404K
UNH icon
97
UnitedHealth
UNH
$382B
$13.8M 0.26%
62,443
-1,699
-3% -$360K
GLNG icon
98
Golar LNG
GLNG
$4.82B
$13.8M 0.26%
461,762
+42,725
+10% +$1.03M
LSXMK
99
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$13.5M 0.26%
445,768
-61,519
-12% -$1.95M
AXP icon
100
American Express
AXP
$224B
$13.2M 0.25%
132,725
-1,541
-1% -$147K
2 3
4
5 6

Similar funds

EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Pinnacle Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Pinnacle Associates held 708 positions worth $5.2B, down 4% from $5.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Pinnacle Associates withdrew a net $370M in Q4 2017, closing 28 positions and reducing 401 holdings. Its most notable exit was Level 3 Communications Inc, an estimated $45.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Pinnacle Associates opened a new position in Intercept Pharmaceuticals, Inc. worth $12.6M.

  • Pinnacle Associates's largest Q4 2017 buy was Intercept Pharmaceuticals, Inc.: 215,290 shares worth $12.6M.
  • Pinnacle Associates added most to Delta Air Lines in Q4 2017, an estimated $7.84M increase.
  • Pinnacle Associates's biggest Q4 2017 reduction was Lam Research, cutting an estimated $19.8M.
  • Pinnacle Associates fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $45.4M.
  • Pinnacle Associates's ten largest holdings make up 18% of its $5.2B portfolio in Q4 2017.
  • Pinnacle Associates opened 42 new positions and closed 28 in Q4 2017.
  • Pinnacle Associates's portfolio value fell 4% quarter-over-quarter to $5.2B.

Based on Pinnacle Associates's 13F filing for Q4 2017, filed 12 Feb 2018.